Salvianolic acid YCAS# 1638738-76-7 |
- Salvianolic acid B
Catalog No.:BCN6106
CAS No.:115939-25-8
- Salvianolic acid B; Lithospermic acid B; Danfensuan B
Catalog No.:BCC8249
CAS No.:121521-90-2
- Isosalvianolic Acid B
Catalog No.:BCC8330
CAS No.:930573-88-9
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 1638738-76-7 | SDF | Download SDF |
| PubChem ID | 97182154 | Appearance | Powder |
| Formula | C36H30O16 | M.Wt | 718.6 |
| Type of Compound | Phenylpropanoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2S)-2-[(E)-3-[(2R,3S)-3-[(1S)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]carbonyl-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydro-1-benzofuran-4-yl]prop-2-enoyl]oxy-3-(3,4-dihydroxyphenyl)propanoic acid | ||
| SMILES | C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C3C(C(OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O | ||
| Standard InChIKey | SNKFFCBZYFGCQN-DUMGGQTMSA-N | ||
| Standard InChI | InChI=1S/C36H30O16/c37-20-6-1-16(11-24(20)41)13-27(34(45)46)50-29(44)10-5-18-3-9-23(40)33-30(18)31(32(52-33)19-4-8-22(39)26(43)15-19)36(49)51-28(35(47)48)14-17-2-7-21(38)25(42)12-17/h1-12,15,27-28,31-32,37-43H,13-14H2,(H,45,46)(H,47,48)/b10-5+/t27-,28-,31-,32-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Salvianolic acid Y is a new protector of PC12 cells against hydrogen peroxide-induced injury from Salvia officinalis. |
| In vitro | Salvianolic acid Y: a new protector of PC12 cells against hydrogen peroxide-induced injury from Salvia officinalis.[Pubmed: 25569522 ]Molecules. 2015 Jan 6;20(1):683-92.Salvianolic acid Y (TSL 1), a new phenolic acid with the same planar structure as salvianolic acid B, was isolated from Salvia officinalis. |
| Structure Identification | Phytomedicine. 2018 May 15;44:138-147.A quality marker study on salvianolic acids for injection.[Pubmed: 29544864 ] The quality of Chinese medicine (CM) has being an active and challenging research area for CM. Prof. Chang-Xiao Liu et al first proposed the concept of quality marker (Q-Marker) for the quality evaluation and control on CM. This article describe the exploratory studies of Q-Marker in salvianolic acids for injection (SAI) based on this new concept. This study was designed to screen Q-Marker of SAI and establish its quality control method based on the concept of CM Q-Marker. |
Salvianolic acid Y Dilution Calculator
Salvianolic acid Y Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3916 mL | 6.958 mL | 13.9159 mL | 27.8319 mL | 34.7899 mL |
| 5 mM | 0.2783 mL | 1.3916 mL | 2.7832 mL | 5.5664 mL | 6.958 mL |
| 10 mM | 0.1392 mL | 0.6958 mL | 1.3916 mL | 2.7832 mL | 3.479 mL |
| 50 mM | 0.0278 mL | 0.1392 mL | 0.2783 mL | 0.5566 mL | 0.6958 mL |
| 100 mM | 0.0139 mL | 0.0696 mL | 0.1392 mL | 0.2783 mL | 0.3479 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 7beta-Hydroxyrutaecarpine
Catalog No.:BCN6500
CAS No.:163815-35-8
- YM 90709
Catalog No.:BCC7149
CAS No.:163769-88-8
- Auristatin F
Catalog No.:BCC5522
CAS No.:163768-50-1
- WIN 64338 hydrochloride
Catalog No.:BCC6914
CAS No.:163727-74-0
- Pazufloxacin mesilate
Catalog No.:BCC9114
CAS No.:163680-77-1
- Kadsulignan L
Catalog No.:BCN3627
CAS No.:163660-06-8
- Evofolin C
Catalog No.:BCN4695
CAS No.:163634-05-7
- Fmoc-D-Trp(Boc)-OH
Catalog No.:BCC3561
CAS No.:163619-04-3
- Kadsulignan N
Catalog No.:BCN3631
CAS No.:163564-58-7
- Vilazodone
Catalog No.:BCC2040
CAS No.:163521-12-8
- Vilazodone Hydrochloride
Catalog No.:BCC2041
CAS No.:163521-08-2
- Triptoquinonide
Catalog No.:BCN1724
CAS No.:163513-81-3
- Androstenediol-3-acetate
Catalog No.:BCC8829
CAS No.:1639-43-6
- 8(17),12E,14-Labdatrien-20-oic acid
Catalog No.:BCN7396
CAS No.:1639257-36-5
- 12E,14-Labdadien-20,8beta-olide
Catalog No.:BCN7395
CAS No.:1639257-37-6
- Kaempferol-3-O-(6''-O-cis-coumaryl)glucoside
Catalog No.:BCN1538
CAS No.:163956-16-9
- Longiferone B
Catalog No.:BCN7378
CAS No.:1639810-67-5
- Clerodenoside A
Catalog No.:BCN1725
CAS No.:164022-75-7
- LY 311727
Catalog No.:BCC7728
CAS No.:164083-84-5
- AM630
Catalog No.:BCC1353
CAS No.:164178-33-0
- Phosphoramidon Disodium Salt
Catalog No.:BCC5484
CAS No.:164204-38-0
- Boc-D-Phe(4-NH2)-OH
Catalog No.:BCC3155
CAS No.:164332-89-2
- Immepip dihydrobromide
Catalog No.:BCC6853
CAS No.:164391-47-3
- KPT-9274
Catalog No.:BCC6461
CAS No.:1643913-93-2
Salvianolic acid Y: a new protector of PC12 cells against hydrogen peroxide-induced injury from Salvia officinalis.[Pubmed:25569522]
Molecules. 2015 Jan 6;20(1):683-92.
Salvianolic acid Y (TSL 1), a new phenolic acid with the same planar structure as salvianolic acid B, was isolated from Salvia officinalis. The structural elucidation and stereochemistry determination were achieved by spectroscopic and chemical methods, including 1D, 2D-NMR (1H-1H COSY, HMQC and HMBC) and circular dichroism (CD) experiments. The biosynthesis pathway of salvianolic acid B and Salvianolic acid Y (TSL 1) was proposed based on structural analysis. The protection of PC12 cells from injury induced by H2O2 was assessed in vitro using a cell viability assay. Salvianolic acid Y (TSL 1) protected cells from injury by 54.2%, which was significantly higher than salvianolic acid B (35.2%).
A quality marker study on salvianolic acids for injection.[Pubmed:29544864]
Phytomedicine. 2018 May 15;44:138-147.
BACKGROUND: The quality of Chinese medicine (CM) has being an active and challenging research area for CM. Prof. Chang-Xiao Liu et al first proposed the concept of quality marker (Q-Marker) for the quality evaluation and control on CM. This article describe the exploratory studies of Q-Marker in salvianolic acids for injection (SAI) based on this new concept. PURPOSE: This study was designed to screen Q-Marker of SAI and establish its quality control method based on the concept of CM Q-Marker. METHODS: Based on the concept of CM Q-Marker, the SAI was investigated for the identification of chemical components and their sources. The pharmacological effects on cerebral ischemia and reperfusion induced injury in rats were also investigated. Furthermore, the target cell extracts and pharmacokinetic studies were conducted to screen Q-Markers. Finally, the fingerprints and determination based on Q-Markers were established to assess the quality of SAI more effectively. RESULTS: Overall, 20 constituents in SAI were identified. It was found that salvianolic acid B (SA-B), rosmarinic acid (RA), lithospermic acid (LA), salvianolic acid D (SA-D) and Salvianolic acid Y (SA-Y) are major chemical components of SAI. Based on chemical components identifications, analysis of their sources, target cell extracts and pharmacokinetic studies, four phenolic acids, namely SA-B, RA, LA and SA-D, were screened and determined as effective Q-Markers of SAI. CONCLUSION: This study demonstrated that the described method is a powerful approach for detecting Q-Markers, which can be used as control index for the quality assessment of CM.
